Monopar (MNPR) Secures $17.7M for Groundbreaking Cancer and Rare Disease Therapies
Monopar Therapeutics Inc. (MNPR) is a clinical-stage biotechnology company revolutionizing the treatment of rare diseases and ...
Read moreDetailsMonopar Therapeutics Inc. (MNPR) is a clinical-stage biotechnology company revolutionizing the treatment of rare diseases and ...
Read moreDetails© 2022 Global Market Bulletin. All Rights Reserved.